Daily non-political popular news in brief.
Heart failure: Intervention possibilities from imaging programmed cell loss
04-03-2007 · EurekAlert!Using a nuclear medicine technique and molecular imaging to "see" programmed cell loss -- the body's normal way of getting rid of unneeded or abnormal cells -- may help in early identification of those individuals who are at risk of developing heart failure, say researchers in the April Journal of Nuclear Medicine.
Read more »
Keywords: heart, failure, intervention, possibilities, imaging, programmed, cell, loss, possibility
« Previous | Next »
Similar news on "Heart failure: Intervention possibilities from imaging programmed cell loss":
- Muscle stem cells may offer a new treatment option for congestive heart failure
03-25-2007 · EurekAlert!
As a new wave of stem cell research continues, cardiologists are trying to tap into the self-renewing cells' life-saving potential. Scientists have performed the first US controlled, randomized Phase I clinical trial using a three-dimensional guided catheter system to deliver muscular stem cells to the heart. The study was presented today at the American College of Cardiology's Innovation in Intervention: i2 Summit in New Orleans.
Similar news · Read more »
- Heart failure patients benefit from nurse-led intervention
11-05-2007 · EurekAlert!
Heart failure patients are more likely to comply with important non-medication interventions, such as fluid and salt restrictions and regular weighing, when they have intensive support from a heart failure nurse and multidisciplinary team than if they do not, researchers reported at the American Heart Association's Scientific Sessions 2007.
Similar news · Read more »
- First human trial tests stem-cell-based treatment for heart attacks
03-25-2007 · EurekAlert!
Previous research on the efficacy of stem cell therapy for heart repair has shown possible benefit from mesenchymal stem cells (MSCs) -- cells found in bone marrow that create connective tissue, bone and cartilage. A study presented today at the American College of Cardiology's Innovation in Intervention: i2 Summit reveals the results of the first human trial using MSCs for the treatment of myocardial infarction (MI, or heart attack).
Similar news · Read more »
- Specific type of cell death may accelerate decompensated heart failure
07-05-2007 · UT Southwestern Medical Center
Autophagy, a normal process by which cells eat their own proteins to provide needed resources to the body in times of stress, may paradoxically cause harm to hearts already weakened by disease, researchers from UT Southwestern Medical Center have found.
Similar news · Read more »
- New technique to 'see' and protect transplants successful in diabetic animal model
07-29-2007 · EurekAlert!
Researchers at Johns Hopkins have found a way to overcome a major stumbling block to developing successful insulin-cell transplants for people with type I diabetes. They developed a new technique encapsulates the insulin-producing cells in magnetic capsules, using an FDA-approved iron compound with an off-label use, which can be tracked by magnetic resonance imaging (MRI). The product, tested in swine and diabetic mice, also simultaneously avoids rejection by the immune system, likely a major reason for transplant failure.
Similar news · Read more »
- Antioxidant overload may underlie a heritable human disease
08-09-2007 · EurekAlert!
Despite the popular notion that antioxidants, such as vitamins C and E, offer health-promoting benefits by protecting against damaging free radicals, a new study in the Aug. 10 issue of the journal Cell reveals that, in fact, balance is the key. The researchers show in mice that an overload of natural antioxidants can actually lead the heart to failure.
Similar news · Read more »
- Pregnancy-related heart failure explained, symptoms reversed by simple hormone blocker
02-08-2007 · EurekAlert!
A new study reveals the mechanism responsible for a rare but potentially devastating form of heart failure that sometimes afflicts women late in pregnancy or shortly following childbirth, researchers have reported in the Feb. 9, 2007, issue of Cell, a publication of Cell Press. The so-called postpartum cardiomyopathy (PPCM) -- which is estimated to complicate one in every 1,300 to 4,000 deliveries in the US -- is considered among the leading causes of death among postpartum women in industrialized countries.
Similar news · Read more »
- JCI table of contents: Aug. 9, 2007
08-09-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Aug. 9, 2007, in the JCI, including: "New molecular regulators of hyperthyroidism and goiter"; "Cell death by necrosis leads to heart failure"; "Extent of apoptotic cell death affects risk factor for heart failure"; "New SNP for acute myeloid leukemia"; and "Battle of the bulge: what controls how much we eat."
Similar news · Read more »
- Stem cell therapy shows promise in regenerating damaged muscle in heart attack patients
03-27-2007 · EurekAlert!
Heart attack patients who received an new intravenous adult stem cell therapy, Provacel, experienced a lower number of adverse events, such as cardiac arrhythmias, and had significant improvements in heart, lung and global function compared to those who received a placebo, according to six-month Phase I study data presented at the American College of Cardiology's Innovation in Intervention: i2 Summit in New Orleans on March 25.
Similar news · Read more »
- Taking heart failure to the MAT1
02-06-2007 · EurekAlert!
A gene called mйnage-а-trois 1, or MAT1, plays a crucial role in the function of a master switch for production of energy in the heart cell -- a finding that has important implications for understanding and maybe even treating heart failure.
Similar news · Read more »
